Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries
Cochrane Database of Systematic Reviews · 2023
DOI: 10.1002/14651858.cd013350.pub2 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Cochrane Database of Systematic Reviews, 2023. Verfasst von M Claire Greene und 10 weiteren Autor:innen. Beteiligte Einrichtung: Program on Forced Migration and Health, Columbia University Mailman School of Public Health, New York, New York, USA. Hauptthemen laut MEDLINE: Alcoholism. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 233 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIDA NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Harmful alcohol use is defined as unhealthy alcohol use that results in adverse physical, psychological, social, or societal consequences and is among the leading risk factors for disease, disability and premature mortality globally. The burden of harmful alcohol use is increasing in low- and middle-income countries (LMICs) and there remains a large unmet need for indicated prevention and treatment interventions to reduce harmful alcohol use in these settings. Evidence regarding which interventions are effective and feasible for addressing harmful and other patterns of unhealthy alcohol use in LMICs is limited, which contributes to this gap in services. OBJECTIVES: To assess the efficacy and safety of psychosocial and pharmacologic treatment and indicated prevention interventions compared with control conditions (wait list, placebo, no treatment, standard care, or active control condition) aimed at reducing harmful alcohol use in LMICs. SEARCH METHODS: We searched for randomized controlled trials (RCTs) indexed in the Cochrane Drugs and Alcohol Group (CDAG) Specialized Register, the Cochrane Clinical Register of Controlled Trials (CENTRAL) in the Cochrane Library, PubMed, Embase, PsycINFO, CINAHL, and the Latin American and Caribbean Health Sciences Literature (LILACS) through 12 December 2021. We searched clinicaltrials.gov, the World Health Organization International Clinical Trials Registry Platform, Web of Science, and Opengrey database to identify unpublished or ongoing studies. We searched the reference lists of included studies and relevant review articles for eligible studies. SELECTION CRITERIA: All RCTs comparing an indicated prevention or treatment intervention (pharmacologic or psychosocial) versus a control condition for people with harmful alcohol use in LMICs were included. DATA COLLECTION AND ANALYSIS: We used standard methodological procedures expected by Cochrane. MAIN RESULTS: We included 66 RCTs with 17,626 participants. Sixty-two of these trials contributed to the meta-analysis. Sixty-three studies were conducted in middle-income countries (MICs), and the remaining three studies were conducted in low-income countries (LICs). Twenty-five trials exclusively enrolled participants with alcohol use disorder. The remaining 51 trials enrolled participants with harmful alcohol use, some of which included both cases of alcohol use disorder and people reporting hazardous alcohol use patterns that did not meet criteria for disorder. Fifty-two RCTs assessed the efficacy of psychosocial interventions; 27 were brief interventions primarily based on motivational interviewing and were compared to brief advice, information, or assessment only. We are uncertain whether a reduction in harmful alcohol use is attributable to brief interventions given the high levels of heterogeneity among included studies (Studies reporting continuous outcomes: Tau² = 0.15, Q =139.64, df =16, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Program on Forced Migration and Health, Columbia University Mailman School of Public Health, New York, New York, USA.
- Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
- Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
- Department of Psychiatry, Columbia University/NYSPI, New York, New York, USA.
- Department of Sociomedical Sciences, Columbia University Mailman School of Public Health, New York, New York, USA.
- Department of Psychiatry, UC Davis Medical Center, Sacramento, CALIFORNIA, USA.
Förderung
- NIMH NIH HHS
- NIDA NIH HHS
Zitieren
APA
Greene, M. C., Kane, J., Alto, M., Giusto, A., Lovero, K., Stockton, M., McClendon, J., Nicholson, T., Wainberg, M. L., Johnson, R. M., & Tol, W. A. (2023). Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd013350.pub2
Vancouver
Greene MC, Kane J, Alto M, Giusto A, Lovero K, Stockton M, et al. Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries. Cochrane Database of Systematic Reviews. 2023. doi:10.1002/14651858.cd013350.pub2
BibTeX
@article{Greene2023,
author = {Greene, M Claire and Kane, Jeremy and Alto, Michelle and Giusto, Ali and Lovero, Kathryn and Stockton, Melissa and McClendon, Jasmine and Nicholson, Terriann and Wainberg, Milton L and Johnson, Renee M and Tol, Wietse Anton},
title = {Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries},
journal = {Cochrane Database of Systematic Reviews},
year = {2023},
doi = {10.1002/14651858.cd013350.pub2}
}
EUVIMED